The recently published open-access book, “Handbook of Applied Health Economics in Vaccines”, provides insights into the complexities of vaccine discovery, financing, and distribution. The book explains how standard economic models fall short in the context of vaccines, which offer both individual and population-level benefits. It explores alternative principles that challenge market-based approaches and equips readers with tools to assess costs and benefits through practical exercises. The book offers a comprehensive resource for decision-making in vaccine development and distribution while emphasizing the need to consider broader perspectives beyond economic efficiency.
CHDS faculty Stephen Resch, Stéphane Verguet, and Ankur Pandya have contributed to chapters in the handbook. Resch has contributed as an author for one chapter and co-author for two, focusing on the importance of costing studies, study design, and data analysis in the context of immunization. The chapters address aspects of cost estimation and offer tools and exercises to evaluate vaccination costs and benefits. Verguet and Pandya have contributed to a chapter on health outcomes measurement, exploring measures such as quality-adjusted life years, disability-adjusted life years, and psychometric approaches to evaluate the effectiveness of vaccines and immunization programs.
Learn more: Read the publication, “Handbook of Applied Health Economics in Vaccines”
Learn more: Read the chapter, 2.1 Why Costing Studies Are Needed
Learn more: Read the chapter, 2.3 Designing a Primary Costing Study or Analysis
Learn more: Read the chapter, 2.4 Data Analysis
Learn more: Read the chapter, 3.4 Measuring and Valuing Health Outcomes
Related news: Heart Failure Guidelines Found Borderline Cost-Effective
Related news: Preventing Medical Impoverishment with CEA
Related news: Costing Capacity Roadmap